Many perspectives, 1 simple etiquette

Do You Believe Trump’s Promise to Lower Drug Prices? This Nonpartisan Prophet Does…

Created: 01 February, 2018
Updated: 17 October, 2022
2 min read

President Trump rarely received a standing ovation from the entirety of the audience at his first State of the Union address. One of the rare moments came when he spoke about knocking down America’s outrageous drug prices.

“One of my greatest priorities is to reduce the price of prescription drugs. In many other countries, these drugs cost far less than what we pay in the United States. That is why I have directed my administration to make fixing the injustice of high drug prices one of our top priorities. Prices will come down.”

Many are skeptical of his declaration, especially since he mentioned combatting high drug prices during his campaign and no action took place in 2017.

There’s some hope this time will be different. Not only did President Trump mention drug prices in his State of the Union, but just one day prior, President Trump put in place a new Health and Human Services Secretary (Alex Azar) and charged him with finding a solution to bringing prescription prices down. At the swearing in Trump stated, “He’s going to get those prescription drug prices way down.”

Should you believe 2018 President Trump? Well, one of our most nonpartisan barometers of future action seems to believe him.

Upon market-close the day after the State of the Union, pharmaceutical stocks were smashed.

Some of the larger producers of medical drugs were hit hard:

Merck & Co. (ticker: MRK) lost 2.31% or about $3.8 billion off its market cap.Amgen Inc. (ticker: AMGN), dropped 2.73% or about $3.8 billion.AbbVie Inc. (ticker: ABBV), fell 3.16% or about A$5.8 billion.Mylan NV (ticker: MYL) lost 2.66% or about $644 million.Gilead Sciences Inc. (ticker: GILD) sunk 4% or about $4.6 billion.Bristol-Myers Squibb Co. (ticker: BMY) was hit for 2.13% or about $2.2 billion.The total market cap lost by the companies above comes out to $20.8 billion. That’s a lot of money that fled pharmaceuticals, and there’s nothing partisan about the decisions behind making or losing money in the markets. The markets are betting President Trump’s words turn into actions.

Now we just have to wait and see if the markets bet correctly.

© 2018 Free Wheel Media. The article originally published on FreeWheelUs, and was republished with permission and by request of Free Wheel Media.

Read more

fair maps
Gerrymandering Reform: Are We Asking the Wrong Question?
Photo Credit:  ...
01 March, 2024
7 min read
joined hands
10 Reasons Why Americans Are Not as Divided as You Think
Photo by on  Party leaders, politicians, and media pundits and talking heads would have US voters b...
28 February, 2024
7 min read
LetUsVote: New Campaign Launches to End Discrimination Against Independent Voters
Open Primaries, in partnership with Unite America, announced the launch of LetUsVote Wednesday, a nationwide initiative that aims to mobilize and empower independent voters, who make up the largest voting bloc in the US but are treated like second-class voters....
27 February, 2024
4 min read
For Good or Bad, Primary Changes May Be Coming to Elections Near You
Photo Credit:  The last couple of years have seen an increase in states looking to change their prim...
26 February, 2024
4 min read
The Primary Problem: Only 8% of Voters Elect 83% of Our Representatives
In his latest podcast, former Democratic presidential candidate and Forward Party Co-Founder Andrew ...
26 February, 2024
3 min read
Blame This One on Secretary of State Weber
Eight years ago, there was a competition still in play between Bernie Sanders and Hillary Clinton wh...
26 February, 2024
4 min read